Besides, relative expression of EMT markers in the tumor enriched ACT1lowCD68+ macrophages of CRC patients further suggested that ACT1 knockdown in macrophages involved in adenoma-adenocarcinoma transition. This evidence concerns the gene TRAF3IP2 and neoplasm.